AppliedVR

AppliedVR, founded in 2015, is at the forefront of virtual reality therapeutics, a burgeoning field that merges Enterprise Software, Health Care, and VR/AR. The company is headquartered in the United States and is renowned for pioneering Immersive Therapeutics (ITx), leveraging VR for medical applications.

Their premier product, RelieVRx®, is the first FDA-authorized, VR-based device for treating chronic lower back pain, reaching a vast U.S. market of 72 million adults. The product stands out by integrating cognitive behavioral therapy into an immersive experience, proven to reduce pain in trials involving over 1,200 patients. Unique achievements like receiving a dedicated CMS code highlight its potential for wide accessibility.

Backed by a $36.00M Series B investment from notable investors such as F-Prime Capital, Sway Ventures, Jazz Venture Partners, and SVB Capital, AppliedVR is poised for continued growth and innovation within digital therapeutics.